AzTrials
AzTrials

Smoking CessationNCT02585206

Optimizing Text Messaging to Improve Adherence to Web-Based Cessation Treatment

A study testing Personalization, Integration and Dynamic Tailoring in people with Smoking Cessation, run by Truth Initiative at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is comprised of 2 phases to study the impact of a text message system on overall adherence to a web-based smoking cessation program. Phase I uses a full factorial design to identify the most optimal text message intervention to maximize adherence to the BecomeAnEX.org smoking cessation program. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Smoking Cessation
What is being tested?
Personalization, Integration and Dynamic Tailoring
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,485 participants
Where
1 siteUnited States
Study dates
29 Mar 2018to 10 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • US residency
  • Current smoker
  • Access to and willingness to receive text messages on a mobile phone
  • Access to Internet
  • Access to and willingness to receive email communication from study personnel

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Truth Initiative

    Washington D.C., District of Columbia, 20001

Other trials in United States

About this study

This study is comprised of 2 phases to study the impact of a text message system on overall adherence to a web-based smoking cessation program. Phase I uses a full factorial design to identify the most optimal text message intervention to maximize adherence to the BecomeAnEX.org smoking cessation program. Phase II is a randomized controlled trial that compares regular BecomeAnEX users to those who will receive the optimized text message intervention (from Phase I) in conjunction with BecomeAnEX for impact on long-term abstinence.

Read the detailed description

This study is comprised of 2 active phases, all conducted with registered users on BecomeAnEX.org, a well-established smoking cessation website.

Phase I involves the initial development and optimization of the text message intervention. The investigators will examine the impact of 4 experimental text message intervention features on smokers' adherence to a web-based cessation intervention during the first 3 months of program enrollment. The investigators will utilize a full factorial design where participants will be randomized to 1 of 2 levels of each of the following features: 1) personalization (yes/no), 2) integration (yes/no), 3) dynamic tailoring (yes/no), and 4) message intensity (standard vs. decreasing). The primary outcome in Phase I will be a composite metric of utilization.

Phase II involves a 2-arm randomized trial that compares WEB alone to WEB plus the text message intervention from Phase I that yields optimal adherence (WEB+OA_TXT). The randomized trial will use a repeated measures design, with assessments at baseline, 3, 9, and 15 months. Follow-ups at 3, 9, and 15 months correspond to 0, 6, and 12 months post-treatment. The primary outcome is 30-day point prevalence abstinence (ppa) at 9-months. The investigators will assess and validate smoking status at all follow-ups. Other outcomes include motivation to quit, quit attempts, and continuous abstinence.

Being tested
Personalization, Integration, Dynamic Tailoring, Message Intensity, Optimal-Adherence Text
Keywords
Mobile Phone, Text Messaging, Internet, Tobacco Use
Medical subject headings
Smoking Cessation, Tobacco Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PersonalizationBehavioural

    Phase I Factor

    Personalized text messages using the participant's username and gender ("Check out the EX Community for tips/support from other men who have quit. They've been there and can help you do this, QuitForever!"). Both data points will be pulled from BecomeAnEX registration data.

  • IntegrationBehavioural

    Phase I Factor

    Interactive messages to facilitate engagement via text with the 6 interactive intervention components of the BecomeAnEX web intervention:

    Set your quit date Cigarette tracker Beat your smoking triggers Build your support system Choose a quit smoking aid Community

    Integration will allow interaction with the web-based program via text message; for example, when a user sets a quit date via the website, it will trigger text messages tailored to the quit date; likewise, if a user sets a quit date via the text system, it will be populated in the website and drive the user experience online.

  • Dynamic TailoringBehavioural

    Individually tailored message to remind/reinforce users about BecomeAnEX information/tools they have already used, or to prompt users to take actions they have not yet taken.

  • Message IntensityBehavioural

    Phase I Factor

    Varying levels of text message intensity over a 12-week period.

  • Optimal-Adherence TextBehavioural

    Also called OA_TXT

    Optimal-adherence text message intervention developed in Phase I

Study groups in NCT02585206
Study groupRoleWhat they receive
Arm 1No interventionAll 4 factors off - standard text message program Personalization OFF Integration OFF Dynamic Tailoring OFF Message Intensity OFF
Arm 2Active comparatorPersonalization OFF Integration OFF Dynamic Tailoring OFF Message Intensity ON
Receives: Behavioral: Message Intensity
Arm 3Active comparatorPersonalization OFF Integration OFF Dynamic Tailoring ON Message Intensity OFF
Receives: Behavioral: Dynamic Tailoring
Arm 4Active comparatorPersonalization OFF Integration OFF Dynamic Tailoring ON Message Intensity ON
Receives: Behavioral: Dynamic Tailoring; Behavioral: Message Intensity
Arm 5Active comparatorPersonalization OFF Integration ON Dynamic Tailoring OFF Message Intensity OFF
Receives: Behavioral: Integration
Arm 6Active comparatorPersonalization OFF Integration ON Dynamic Tailoring OFF Message Intensity ON
Receives: Behavioral: Integration; Behavioral: Message Intensity
Arm 7Active comparatorPersonalization OFF Integration ON Dynamic Tailoring ON Message Intensity OFF
Receives: Behavioral: Integration; Behavioral: Dynamic Tailoring
Arm 8Active comparatorPersonalization OFF Integration ON Dynamic Tailoring ON Message Intensity ON
Receives: Behavioral: Integration; Behavioral: Dynamic Tailoring; Behavioral: Message Intensity
Arm 9Active comparatorPersonalization ON Integration OFF Dynamic Tailoring OFF Message Intensity OFF
Receives: Behavioral: Personalization
Arm 10Active comparatorPersonalization ON Integration OFF Dynamic Tailoring OFF Message Intensity ON
Receives: Behavioral: Personalization; Behavioral: Message Intensity
Arm 11Active comparatorPersonalization ON Integration OFF Dynamic Tailoring ON Message Intensity OFF
Receives: Behavioral: Personalization; Behavioral: Dynamic Tailoring
Arm 12Active comparatorPersonalization ON Integration OFF Dynamic Tailoring ON Message Intensity ON
Receives: Behavioral: Personalization; Behavioral: Dynamic Tailoring; Behavioral: Message Intensity
Arm 13Active comparatorPersonalization ON Integration ON Dynamic Tailoring OFF Message Intensity OFF
Receives: Behavioral: Personalization; Behavioral: Integration
Arm 14Active comparatorPersonalization ON Integration ON Dynamic Tailoring OFF Message Intensity ON
Receives: Behavioral: Personalization; Behavioral: Integration; Behavioral: Message Intensity
Arm 15Active comparatorPersonalization ON Integration ON Dynamic Tailoring ON Message Intensity OFF
Receives: Behavioral: Personalization; Behavioral: Integration; Behavioral: Dynamic Tailoring
Arm 16Active comparatorPersonalization ON Integration ON Dynamic Tailoring ON Message Intensity ON
Receives: Behavioral: Personalization; Behavioral: Integration; Behavioral: Dynamic Tailoring; Behavioral: Message Intensity
WEBNo interventionPhase II arm. Full access to standard BecomeAnEX.org web-based smoking cessation program.
WEB+OA_TXTActive comparatorPhase II arm. Full access to standard BecomeAnEX.org web-based smoking cessation program PLUS optimal-adherence text message program from Phase I.
Receives: Behavioral: Optimal-Adherence Text

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Phase I - Composite adherence metric

    The investigators will create a composite metric of adherence for each Phase I participant using a weighted sum of their total number of number of visits, as well as of their page views, time on site, and use of the 6 interactive components of the site per visit during 3 months post-enrollment.

    Measured: 3 months

  2. Phase II - 30-day point prevalence abstinence

    Self-reported 30-day point prevalence abstinence at 9 months post randomization

    Measured: 9 months post randomization

Secondary outcomes (2)
  1. Phase II - 30day point prevalence abstinence

    Self-reported 30-day point prevalence abstinence at 3 months post randomization

    Measured: 3 months post randomization

  2. Phase II - 30day point prevalence abstinence

    Self-reported 30-day point prevalence abstinence at 15 months post randomization

    Measured: 15 months post randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2015 (estimated)
  2. Study start29 Mar 2018
  3. Primary completion19 Dec 2019
  4. Study completion10 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
Phase I: full factorial design of four factors each with 2 levels (16 arms); Phase II: 2-arm randomized trial
Masking
Single blind
Who is masked
Participant
Enrolment
1,485 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02585206
Sponsor's protocol ID
1R01DA038139
Status last verified
Sep 2026
First submitted
22 Oct 2015
Last updated
5 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Graham AL, Jacobs MA, Cohn AM, Cha S, Abroms LC, Papandonatos GD, Whittaker R. Optimising text messaging to improve adherence to web-based smoking cessation treatment: a randomised control trial protocol. BMJ Open. 2016 Mar 30;6(3):e010687. doi: 10.1136/bmjopen-2015-010687.

    PubMed 27029775
  • Graham AL, Papandonatos GD, Cha S, Amato MS, Jacobs MA, Cohn AM, Abroms LC, Whittaker R. Effectiveness of an optimized text message and Internet intervention for smoking cessation: A randomized controlled trial. Addiction. 2022 Apr;117(4):1035-1046. doi: 10.1111/add.15677. Epub 2021 Sep 28.

    PubMed 34472676
  • Graham AL, Papandonatos GD, Jacobs MA, Amato MS, Cha S, Cohn AM, Abroms LC, Whittaker R. Optimizing Text Messages to Promote Engagement With Internet Smoking Cessation Treatment: Results From a Factorial Screening Experiment. J Med Internet Res. 2020 Apr 2;22(4):e17734. doi: 10.2196/17734.

    PubMed 32238338

Questions about this trial

What is this clinical trial studying?

A study testing Personalization, Integration and Dynamic Tailoring in people with Smoking Cessation, run by Truth Initiative at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Phase I - Composite adherence metric (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02585206, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02585206 | AzTrials